South Korea Cell Therapy and Tissue Engineering Market was valued at USD 3 Billion in 2022 and is projected to reach USD 6 Billion by 2030, growing at a CAGR of 8.0% from 2024 to 2030.
South Korea's Cell Therapy and Tissue Engineering Market: Applications and Industry Requirements
South Korea is rapidly emerging as a significant player in the global cell therapy and tissue engineering market. With advancements in regenerative medicine and supportive government policies, the country is witnessing substantial growth in these sectors.
In 2023, South Korea's cell therapy market generated approximately USD 368.0 million in revenue and is projected to reach USD 1,399.3 million by 2030, reflecting a compound annual growth rate (CAGR) of 21% from 2024 to 2030. This growth is primarily driven by the increasing adoption of autologous therapies, which accounted for the largest revenue share in 2023. Allogeneic therapies are also gaining traction, anticipated to register the fastest growth during the forecast period.
The tissue engineering segment is also experiencing significant expansion. The global tissue engineering market was valued at USD 13.50 billion in 2024 and is expected to reach USD 22.94 billion by 2030, growing at a CAGR of 9.20%. South Korea's focus on bone regeneration and wound healing technologies contributes to this upward trend, with innovations in biocompatible materials and surgical techniques enhancing bone healing and fracture management.
Several factors contribute to this robust growth:
Regulatory Support: The enactment of the Act on Advanced Regenerative Medicine and Advanced Biological Products (ARMAB) in 2019 streamlined the approval process for cell therapy products, fostering innovation while ensuring safety and efficacy.
Investment in Research and Development: Both public and private sectors are investing heavily in R&D, leading to the development of novel therapies and expanding the market landscape.
Increasing Prevalence of Chronic Diseases: The rising incidence of chronic and degenerative diseases has heightened the demand for advanced therapeutic solutions, positioning cell therapy and tissue engineering as viable treatment options.
For industries operating within this market, several requirements are essential:
Compliance with Regulatory Standards: Adherence to the stringent guidelines set by the Ministry of Food and Drug Safety (MFDS) is crucial for market entry and product approval.
Investment in Advanced Manufacturing Facilities: Establishing state-of-the-art facilities equipped with the latest technologies ensures the production of high-quality, safe, and effective products.
Collaboration with Research Institutions: Partnering with academic and research organizations can accelerate innovation and provide access to cutting-edge developments in the field.
As someone deeply involved in the regenerative medicine sector, I've observed firsthand the dynamic evolution of South Korea's cell therapy and tissue engineering market. The collaborative efforts between the government, industry players, and research institutions have created a conducive environment for growth and innovation. Companies that navigate the regulatory landscape effectively and invest in research and development are well-positioned to capitalize on the burgeoning opportunities within this market.
Get an In-Depth Research Analysis of the South Korea Cell Therapy and Tissue Engineering Market Size And Forecast [2025-2032]
Â
Betalin Therapeutics
BioCardia
Inc BioReliance Corporation
Biosolution Co.
Brainstorm Cell Therapeutics
Inc MaxCyte
Inc Medigene AG
MEDIPOST CO.
Mesoblast Limited
Miromatrix Medical
Inc
MolMed S.p.A
Mustang Bio
Inc NantKwest
Inc
Neuralstem
Inc NexImmune
Inc
Nohla Therapeutics
Inc ReNeuron Group plc
Richter-Helm BioLogics GmbH & Co. KG
RoosterBio
Inc Ros Inc
Rubius Therapeutics
Inc
Sangamo Therapeutics
Inc Voyager Therapeutics
Inc Waisman Biomanufacturing
WindMIL Therapeutics
Inc
Wuxi App Tec
Inc
ReNeuron Group plc
Richter-Helm BioLogics GmbH & Co. KG
RoosterBio
Inc Ros Inc
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Cell Therapy and Tissue Engineering Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Cell Therapy and Tissue Engineering Market
Autologous Cell Therapy
Allogeneic Cell Therapy
Universal Cell Therapy
Stem Cells
T cell Therapy
Mesenchymal Stem Cells
Induced Pluripotent Stem Cells (iPSCs)
Cancer Therapy
Cardiovascular Disorders
Neurological Disorders
Musculoskeletal Disorders
Autoimmune Diseases
Intravenous
Intraarterial
Intramuscular
Subcutaneous
Hospitals
Research Laboratories
Academic Institutes
Biotechnology Companies
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Cell Therapy and Tissue Engineering Market Research Analysis
1. Introduction of the South Korea Cell Therapy and Tissue Engineering Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Cell Therapy and Tissue Engineering Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Cell Therapy and Tissue Engineering Market, By Type
6. South Korea Cell Therapy and Tissue Engineering Market, By Application
7. South Korea Cell Therapy and Tissue Engineering Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Cell Therapy and Tissue Engineering Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/